SECsense Logo

Lipocine Inc. 8-K Report: Key Insights for Investors - January 13, 2025

$LPCN
Form 8-K
Filed on: 2025-01-13
Source
Lipocine Inc. 8-K Report: Key Insights for Investors - January 13, 2025

Based on the provided section of the financial report, here are the key insights extracted:

  1. Company Identification:
  • Name: Lipocine Inc.
  • CIK: 0001535955
  • SEC File Number: 001-36357
  • Tax ID: 99-0370688
  • Address: 675 Arapeen Drive, Suite 202, Salt Lake City, UT 84108
  • Contact Number: (801) 994-7383
  1. Report Details:
  • Form Type: 8-K (Current report)
  • Report Date: January 13, 2025
  1. Financial Information:
  • Currency: USD (U.S. Dollars)
  • Common Stock Par Value: $0.0001 per share
  • Ticker Symbol: LPCN
  • Exchange: NASDAQ
  1. Context:
  • The report pertains to a specific date, which is both the start and end date: January 13, 2025.
  1. Units of Measure:
  • The report includes units for financial measures in USD and shares, indicating a focus on stock performance or financial metrics per share.

Summary

This section of the financial report indicates that Lipocine Inc. filed an 8-K report on January 13, 2025, providing essential details about the company, its stock information, and the context of the filing. It is critical for investors and analysts to review such filings for updates related to the company's operations, financial condition, or significant events that may affect stock performance.